Ensayos clínicos

8.676 ensayos encontrados

ReclutandoClinicalTrials.gov

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures: An International Multicenter Prospective Study

OBSERVATIONALInicio: 10 de mar de 2026ID: NCT07027306

ReclutandoFase 2ClinicalTrials.gov

Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies

INTERVENTIONALInicio: 5 de may de 2020ID: NCT03899155

ReclutandoFase 3ClinicalTrials.gov

Phase 3 Study of Pembrolizumab in Combination With Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab With or Without Maintenance MK-2870 in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer

INTERVENTIONALInicio: 10 de jun de 2024ID: NCT06422143

ReclutandoClinicalTrials.gov

Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System

INTERVENTIONALInicio: 11 de may de 2021ID: NCT03206814

ReclutandoClinicalTrials.gov

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

OBSERVATIONALInicio: 27 de nov de 2023ID: NCT06212947

ReclutandoClinicalTrials.gov

Validation of the Oncoliq Test for the Early Detection of Breast Cancer.

OBSERVATIONALInicio: 17 de oct de 2025ID: NCT07331506

ReclutandoFase 2ClinicalTrials.gov

A Multi-Centre, Single Arm, Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of GSK4527226 (AL101) in Participants With Early Alzheimer's Disease

INTERVENTIONALInicio: 14 de ago de 2025ID: NCT07105709

ReclutandoFase 2ClinicalTrials.gov

A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

INTERVENTIONALInicio: 30 de jun de 2025ID: NCT06979531

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Years of Age)

INTERVENTIONALInicio: 18 de oct de 2021ID: NCT05092269

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)

INTERVENTIONALInicio: 2 de oct de 2023ID: NCT05755386

ReclutandoFase 3ClinicalTrials.gov

A Randomised, Open-Label, Phase III Study of Saruparib (AZD5305) Plus Camizestrant Compared With Physician's Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of Patients With BRCA1, BRCA2, or PALB2 Mutations and Hormone Receptor Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified) Advanced Breast Cancer (EvoPAR-Breast01)

INTERVENTIONALInicio: 1 de ago de 2024ID: NCT06380751

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Double-blind Study to Compare the Pharmacokinetics Between ABP 234 and Keytruda® (Pembrolizumab) in Participants With Early-stage Non-squamous Non-small Cell Lung Cancer as Adjuvant Treatment Following Resection and Platinum-based Chemotherapy

INTERVENTIONALInicio: 12 de sept de 2024ID: NCT06430866

ReclutandoFase 3ClinicalTrials.gov

A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study

INTERVENTIONALInicio: 9 de sept de 2013ID: NCT01804686

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants With Primary IgA Nephropathy in Combination With Stable Background Therapy

INTERVENTIONALInicio: 15 de jul de 2025ID: NCT06963827

ReclutandoFase 3ClinicalTrials.gov

Phase 3, Randomized, Open-label, Controlled, Multiple Dose, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Etelcalcetide in Pediatric Subjects 28 Days to < 18 Years of Age With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Maintenance Hemodialysis

INTERVENTIONALInicio: 29 de abr de 2019ID: NCT03633708

ReclutandoFase 2ClinicalTrials.gov

A Phase IIb, Randomised, Multicentre, Double-Blind Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

INTERVENTIONALInicio: 5 de dic de 2025ID: NCT07222917

ReclutandoClinicalTrials.gov

Mucopolysaccharidosis VII Disease Monitoring Program (MPS VII DMP)

OBSERVATIONALInicio: 29 de ene de 2018ID: NCT03604835

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Carisbamate (YKP509) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults, With Optional Open-Label Extension

INTERVENTIONALInicio: 28 de abr de 2022ID: NCT05219617

ReclutandoFase 1ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Rheumatoid Arthritis

INTERVENTIONALInicio: 7 de nov de 2021ID: NCT05003934

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

INTERVENTIONALInicio: 16 de jul de 2025ID: NCT07011745